SUMMARY Six strains of Haemophilus influenzae were distributed to 417 United Kingdom laboratories who were asked to test susceptibility of the strains to ampicillin, augmentin, tetracycline, chloramphenicol, and trimethoprim and to test for P lactamase production. Laboratories were also asked to provide details of their methods by completing a questionnaire. The incidence of reports recording sensitive strains as resistant was 8% (ampicillin), 7% (augmentin), 3% (tetracycline), 1% (chloramphenicol), and 12% (trimethoprim). The incidence of reports recording resistant strains as sensitive was 9% (ampicillin), (2% with ,B lactamase producing strains, 24% with non-fl lactamase producing strains), 51% (augmentin), 10% (tetracycline), 20% (chloramphenicol), and 3% (trimethoprim). High error rates were associated with several methods or practices. These included use of general purpose growth media rather than susceptibility testing media and failure to add lysed blood to the media when testing trimethoprim susceptibility; standardise the inoculum; use suitable control strains; and the use of high content discs for testing chloramphenicol, tetracycline, and ampicillin.
asked to provide details of their methods by completing a questionnaire. The incidence of reports recording sensitive strains as resistant was 8% (ampicillin), 7% (augmentin), 3% (tetracycline), 1% (chloramphenicol), and 12% (trimethoprim). The incidence of reports recording resistant strains as sensitive was 9% (ampicillin), (2% with ,B lactamase producing strains, 24% with non-fl lactamase producing strains), 51% (augmentin), 10% (tetracycline), 20% (chloramphenicol), and 3% (trimethoprim). High error rates were associated with several methods or practices. These included use of general purpose growth media rather than susceptibility testing media and failure to add lysed blood to the media when testing trimethoprim susceptibility; standardise the inoculum; use suitable control strains; and the use of high content discs for testing chloramphenicol, tetracycline, and ampicillin.
The United Kingdom national external quality assessment scheme for microbiology (UKNEQAS) has been described previously.' 2 As part of the general bacteriology section of the scheme participants were asked to perform antimicrobial susceptibility tests on strains of established susceptibility. Results of tests on strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae showed high error rates with some strain and antimicrobial agent combinations, differences in interlaboratory error rates, and association between certain methods or practices and error rates.3 4 The species of bacteria distributed were robust and easy to cultivate. Results were not necessarily representative of 347  255  29  69  280   6  245  335  354  333   12  243  336  354  322   85  133  321  350  265   342  261  334  354  327   334  253  37  69  9   4 282  132   19   5   80   28  8  7  2  20   38  19  303  281  341   92  94  91  79  80  2  318  99   98  88  97  99  95  332  12  97   97  89  99  99  93  329  13  96   76  49  94  99  77  6  330  98   91  97  98  99  94  1  322  99   88  93  88  78  97  3 320 99 S = sensitive; R = resistant. 
MEASUREMENT OF ASSOCIATION BETWEEN METHODS AND RESULTS
The association between methods and results was tested by the x2 test to compare the ratios of correct: incorrect results achieved by laboratories using different methods. Unless otherwise stated, the numbers of correct and incorrect results were the combined totals from all strains with all antimicrobial agents. To avoid distortions due to small numbers of laboratories using a particular method association between methods and error rates were tested only when methods were used by a minimum of 20 laboratories. Results achieved with methods used by less than 20 laboratories, or when methods used were not unequivocally stated, have generally not been included in text or tables. The exclusion of these results causes some apparent inconsistency where the sum of laboratories using specific techniques is less than the total using the general method. Thus-for example, although 283 laboratories stated that they used control organisms, only two species were used by more than 20 laboratories, the Oxford strain of staphylococcus by 173, and H influenzae by 74; the apparent shortfall of 36 laboratories comprising those using other species, more than one species, or not supplying the required information. Results DISCREPANCY RATES Table 1 shows the results and error rates of participants for the six strains distributed. The overall error rate for all strain and antimicrobial agent combinations was 8%. APPLICATION OF INOCULUM Table 6 shows the distribution of correct and incorrect results according to the method of application of the inoculum. Those applying the inoculum by swab made proportionally fewer errors than those using a loop (X2 13'54; p < 0001). 414 incorrect, ratio of correct:incorrect 10) and the 127 laboratories using discs manufactured by Mast (3077 correct, 338 incorrect, ratio of correct:incorrect nine). Table 8 shows the amounts of antimicrobial agent in the discs used and the associated error rates. Those using low content (2 gg) ampicillin discs made proportionally fewer errors in testing ampicillin susceptibility than those using discs of higher content (5, 10, 25 ig) (X2 18-94; p < 0-001).
Those using low content (2.5, 5, 10 g) chloramphenicol discs made proportionally fewer errors in testing chloramphenicol susceptibility than those 
p < 0-001). Those using low content (5, l0,g) tetracycline discs made proportionally fewer errors in testing tetracycline susceptibility than those using discs of higher content (25, 30, 50pg) (X2 11 13; p < 0 001). There were insufficient laboratories using disc contents other than 30pg for augmentin, or higher than 5pg for trimethoprim, to permit comparison between results of tests with low and high content discs.
Discussion
The results indicate serious problems in the testing of susceptibility of H influenzae. The incidence of reports recording sensitive strains as resistant was 8% (ampicillin), 7% (augmentin), 3% (tetracycline), 1% (chloramphenicol), and 12% (trimethoprim). The incidence of reports recording resistant strains as sensitive was 9% (ampicillin) (2% with ,B lactamase producing strains, 24% with the non-,B lactamase producing strain), 51% (augmentin), 10% (tetracycline), 20% (chloramphenicol), and 3% (trimethoprim). These figures contrast with those obtained in a previous study' when the incidence of reports recording sensitive strains as resistant was 0 5% (tetracycline), 1-6% (ampicillin), and 6-2% (trimethoprim); the incidence of reports recording resistant strains as sensitive was 37% (tetracycline), 27% (ampicillin), and 67% (trimethoprim). The error rates obtained in the two studies are not strictly comparable, however, as in the earlier study5 results were obtained from strains referred to a reference laboratory after routine testing by a selected group of 25 laboratories. The current study entailed a small number of selected strains tested by a large number of laboratories. Whatever the exact discrepancy rate, spurious reports of sensitivity for the strains resistant to chloramphenicol, tetracycline, ampicillin, and augmentin are disturbing as such errors could have a profound effect on the outcome of treatment. Resistance to ampicillin mediated by # lactamase production was recognised by an average of 98% laboratories compared with only 76% recognising intrinsic resistance in a , lactamase negative strain. Reporting of the P lactamase negative strain as sensitive to augmentin by 51% of laboratories is inconsistent, as augmentin is likely to be more effective than ampicillin against H influenzae only when the strain produces , lactamase. These errors are probably explained by the common use of higher content discs (30 pg, of which 20 pg is amoxycillin) for augmentin than for ampicillin (2pg and 10pg most commonly used).
Only 11 laboratories used a breakpoint method alone or in combination with a disc method, thus precluding a comparison of results obtained by those using breakpoint methods with those using disc methods. Such a comparison would have been useful in assessing whether the claimed advantages of the breakpoint methods over disc diffusion methods would give more reliable results with this group of fastidious organisms.
Association between the use of various media and results was largely confined to trimethoprim testing in that laboratories using media specially designed for susceptibility testing made fewer errors than those using general purpose growth media. We were unable to confirm a previous report5 that tetracycline resistance in H influenzae could be more reliably detected by the use of Oxoid Isosensitest agar than with Oxoid DST agar. Reduction in error rates in testing trimethoprim susceptibility, resulting from the addition of lysed horse blood to the medium, was not unexpected. This effect is well known and has been shown in previous trials with Enterobacteriaceae34 and H influenzae. 5 The high error rate associated with the use of carbon dioxide producing sachets is unexplained. Incubation of tests in an atmosphere containing carbon dioxide produced by other methods gave results no worse than when tests were incubated in air. The results with the carbon dioxide producing sachets clearly warrant further investigation.
As in previous trials34 methods of preparation, standardisation, and application of the inoculum all influenced the error rate. These factors are likely to influence the density of growth, which is critical in disc susceptibility testing.8 The use of a strain of H influenzae as a control organism on each occasion of testing was important in reducing the error rate. Those using the Oxford strain of S aureus did not make proportionally fewer errors than those not using a control. There is no generally recognised control strain of H influenzae available; so we have deposited the sensitive strain (MQCL 1140) in the National Collection of Type Cultures (NCTC strain No 1193 1) for this purpose.
The influence of the amount of antimicrobial agent in the disc on error rates was evident. The use of high content discs was associated with high error rates with chloramphenicol, tetracycline, and ampicillin. Problems associated with the use of high content discs are well known.89 Augmentin discs with high content only (30 pg) are currently commercially available from stock (other contents might be made to order). This seems excessively high compared with the recommended'I 2 pg content for ampicillin discs. We understand from the manufacturers that 3 pg augmentin discs will soon be commercially available.
The high error rates found in this and a previous trial5 suggest that reproducible results might be difficult to achieve by the use of the disc method with H influenzae. In the present trial, however, 41 % of laboratories achieved error rates of less than 5%, and 25% made no errors. Thus reliable results can be obtained with the disc method provided that certain aspects of technique are followed. Care must be exercised in the interpretation of results from surveys such as this since only a few strains were examined, and apparent differences in the efficacy of particular aspects of technique may reflect interactions of technical factors rather than a single factor. The following recommendations, however, are supported by the results of this survey and that of previous work.5 They are in line with recommendations based on previous surveys.34 1 Media specially designed for susceptibility test- ing should be used rather than general purpose growth media. 2 Lysed blood should be added to the media when testing for susceptibility to trimethoprim. 3 The density of the inoculum should be standardised. 4 A control strain of H influenzae should be used on each occasion of testing. 5 Low content discs should be used for testing chloramphenicol (2-5, 5, or 1O gg), tetracycline (5 or 10 pg) ampicillin (2 pg) and augmentin (2pg ampicillin + 1 pg clavulonic acid when these become commercially available).
